Supplements for Autism Spectrum Disorder
Primary Recommendation
Melatonin is the only supplement with strong evidence for use in autism, specifically for treating insomnia, with demonstrated improvements in sleep latency and total sleep time. 1 Beyond melatonin for sleep disturbances, there is insufficient evidence to recommend routine supplementation for core autism symptoms or behavioral improvements in individuals with ASD.
Evidence-Based Supplement Recommendations
Melatonin for Sleep Disturbances
- Melatonin is the first-line pharmacologic treatment for insomnia in children and adolescents with ASD, showing statistically significant improvements in sleep latency (reduced by approximately 40 minutes) and total sleep time (increased by 1.79-1.91 hours). 1
- Melatonin demonstrates effectiveness when behavioral sleep interventions have failed, with improvements typically seen within 4 weeks of treatment initiation. 1
- The evidence base for melatonin is stronger than any other supplement or medication for pediatric insomnia in ASD. 1
Vitamin D
- Vitamin D supplementation may increase serum 25(OH)D levels in children with ASD, but evidence for behavioral improvement is inconsistent and inconclusive. 2
- Consider vitamin D supplementation only if documented deficiency exists (serum 25(OH)D <50 nmol/L), not as routine treatment for autism symptoms. 2
Omega-3 Fatty Acids (PUFAs)
- Evidence for omega-3 fatty acid effectiveness in improving ASD symptoms is limited, though supplementation is feasible and acceptable. 1
- Omega-3 supplementation does not significantly affect core ASD behaviors but may correct documented nutritional deficiencies. 2
- Six RCTs showed no consistent behavioral improvements despite potential correction of fatty acid deficiencies. 2
Multivitamin/Mineral Supplements
- A comprehensive vitamin/mineral supplement showed improvement in nonverbal IQ (+6.7 points vs -0.6 points in controls, p=0.009) in one 12-month RCT, but this represents a single study requiring replication. 3
- Moderate-dose multivitamins (including B6, vitamin C) showed no significant effect on irritability, sleep latency, or periodic leg movements in controlled trials. 1
- Routine multivitamin supplementation cannot be recommended for treating core ASD symptoms based on current evidence. 2
Vitamin B6/Magnesium
- Seven RCTs demonstrated that B6/magnesium supplementation is not helpful for improving ASD symptoms. 2
- This combination should not be recommended despite historical use in autism treatment. 2
Methylcobalamin (Methyl B12)
- Two RCTs reported some improvement in ASD severity, but effects on correcting documented deficiencies were inconclusive. 2
- Insufficient evidence exists to recommend routine use. 2
Folinic Acid
- One RCT reported positive results in improving ASD symptoms measured by behavioral scales, but this represents preliminary evidence requiring confirmation. 2
Critical Clinical Approach
When to Consider Supplements
- Supplements should target documented nutritional deficiencies or specific comorbid symptoms (primarily sleep disturbances), not core autism features. 4, 5
- Screen for actual deficiencies before supplementation: vitamin D levels, iron studies, fatty acid profiles if clinically indicated. 2, 6
- Recognize that gastrointestinal disturbances and restricted diets in ASD may increase risk for true nutritional deficiencies requiring correction. 5, 7
Integration with Standard Care
- Supplements should never substitute for appropriate behavioral and educational interventions, which remain the cornerstone of ASD treatment. 4, 8
- Medication management for comorbid psychiatric symptoms (irritability, aggression, hyperactivity) requires psychiatry referral, not supplement trials. 4, 8
- For irritability and aggression, FDA-approved medications (risperidone 0.5-3.5 mg/day or aripiprazole 5-15 mg/day) have far stronger evidence than any supplement. 4
Common Pitfalls to Avoid
- Do not recommend supplements for core social communication deficits of autism—no supplement treats these fundamental features. 4, 2
- Avoid recommending expensive supplement regimens without documented deficiencies or clear target symptoms. 2, 7
- Do not delay evidence-based behavioral interventions or psychiatric treatment while pursuing supplement trials. 4, 8
- Recognize that most supplement studies in ASD are small, heterogeneous, and lack replication. 2, 7
- Be aware that families commonly use supplements (often the most common medical treatment pursued), so actively inquire about use and provide evidence-based guidance. 5, 6
Practical Algorithm
- Assess for sleep disturbances: If present and behavioral interventions insufficient → trial melatonin 1
- Screen for nutritional deficiencies: If documented deficiency → correct specific deficiency (vitamin D, iron, etc.) 2, 6
- Evaluate for comorbid psychiatric symptoms: If irritability, aggression, hyperactivity, or anxiety → refer to psychiatry for evidence-based medication management, not supplements 4, 8
- Counsel families: Explain limited evidence for supplements treating core autism symptoms; redirect focus to behavioral/educational interventions 4, 2, 7